Last update 04 Dec 2025

NSA-789

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
NSA 789
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System Diseases
Active Indication-
Inactive Indication
Alzheimer DiseaseSchizoaffective disorderSchizophrenia
Originator Organization
Pfizer Inc.Pfizer Inc.
Active Organization-
Inactive Organization
Wyeth AB
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with NSA-789
NCT00892021
/ WithdrawnPhase 1
An Ascending Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NSA-789 Administered Orally to Subjects With Schizophrenia or Schizoaffective Disorder
NCT00795730
/ CompletedPhase 1
An Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of NSA-789 Administered Orally to Healthy Subjects and Subjects With Alzheimer's Disease
NCT00781794
/ WithdrawnPhase 1
A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of Single Oral Doses of NSA-789 on Auditory P50 Suppression in Nonsmoking Patients With Stabilized Schizophrenia
100 Clinical Results associated with NSA-789
Login to view more data
100 Translational Medicine associated with NSA-789
Login to view more data
100 Patents (Medical) associated with NSA-789
Login to view more data
100 Deals associated with NSA-789
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Schizoaffective disorderPhase 1
United States
Wyeth AB
01 May 2009
Alzheimer DiseasePhase 1
United States
Wyeth AB
01 Jan 2009
SchizophreniaPhase 1
United States
Wyeth AB
01 Mar 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free